These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10753450)
61. Mixing of Monoclonal Antibody Formulated Drug Substance Solutions in Square Disposable Vessels. Nakach M; Amine C; Pellet C; Bensaid F; Authelin JR; Wils P J Pharm Sci; 2022 Oct; 111(10):2799-2813. PubMed ID: 35577115 [TBL] [Abstract][Full Text] [Related]
62. [Biopharmaceutics. V. Biopharmaceutical stability and degradation]. Arias I; Cadorniga R Boll Chim Farm; 1974 Nov; 113(11):567-78. PubMed ID: 4464893 [No Abstract] [Full Text] [Related]
63. [Study of the efficacy of the process of mixing hard medicines when dispensing preparations in pharmacies]. Murav'ev IA; Koz'min VD Aptechn Delo; 1965; 14(6):14-9. PubMed ID: 5874961 [No Abstract] [Full Text] [Related]
64. Bioavailability. Davies RO; Zarowny DP; Robin HR; Ruedy J Can Med Assoc J; 1972 Aug; 107(3):183-4. PubMed ID: 5052898 [No Abstract] [Full Text] [Related]
65. Basics of compounding: tips and hints, Part 5: Facilities and equipment. Allen LV Int J Pharm Compd; 2014; 18(5):401-4. PubMed ID: 25577890 [No Abstract] [Full Text] [Related]
67. [On the extraction of drugs: small production apparatus]. Du Ban G Boll Chim Farm; 1965 Aug; 104(8):511-9. PubMed ID: 5855628 [No Abstract] [Full Text] [Related]
68. What is the latest information with reference to mixing of insulin? Kulkarni K Diabetes Educ; 1983; 9(1):45. PubMed ID: 6341023 [No Abstract] [Full Text] [Related]
74. An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process. Andrade C; Arnold L; Motabar D; Aspelund M; Tang A; Hunter A; Chung WK Biotechnol Prog; 2019 Jan; 35(1):e2720. PubMed ID: 30298991 [TBL] [Abstract][Full Text] [Related]
75. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality. Gikanga B; Chen Y; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994 [TBL] [Abstract][Full Text] [Related]
76. Building biomanufacturing capacity--the chapter and verse. Kamarck ME Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126 [TBL] [Abstract][Full Text] [Related]
77. Multivariate statistical monitoring as applied to clean-in-place (CIP) and steam-in-place (SIP) operations in biopharmaceutical manufacturing. Roy K; Undey C; Mistretta T; Naugle G; Sodhi M Biotechnol Prog; 2014; 30(2):505-15. PubMed ID: 24532460 [TBL] [Abstract][Full Text] [Related]
78. [Biopharmaceutical aspects of parenteral drug formulations]. Pflegel H Pharmazie; 1982 Apr; 37(4):307-18. PubMed ID: 7048344 [No Abstract] [Full Text] [Related]
79. Mixing in process vessels used in biopharmaceutical manufacturing. Ram K; Vickroy TB; Lamb KA; Slater NK; Dennis JS; Duffy LE Biotechnol Prog; 2000; 16(2):244-7. PubMed ID: 10753450 [TBL] [Abstract][Full Text] [Related]